title: Aprepitant for erlotinib-induced pruritus.
authors.forename: Bruno
authors.initials: B
authors.lastname: Vincenzi
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Tonini
authors.forename: Daniele
authors.initials: D
authors.lastname: Santini
mesh_terms: D000328:Adult; D000368:Aged; D000077608:Aprepitant; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D008297:Male; D009025:Morpholines / Q000627:therapeutic use*; D064729:Neurokinin-1 Receptor Antagonists; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011537:Pruritus / Q000139:chemically induced / Q000188:drug therapy*; D011799:Quinazolines / Q000009:adverse effects*
chemical_list: D009025:Morpholines; D064729:Neurokinin-1 Receptor Antagonists; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000077608:Aprepitant; D000069347:Erlotinib Hydrochloride